DNMT3A and acute myeloid leukemia: OCI-AML-2 is characterized by methyltransferase 3 A (DNMT3A) mutation occurring in about 20–30% of cases with AML, responsible for an abnormal DNA methylation pattern and associated with poor outcomes in AML [14,15].